InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: GoldRus post# 74802

Monday, 05/27/2013 4:24:35 PM

Monday, May 27, 2013 4:24:35 PM

Post# of 158400
Basically the FDA will tell them whether they can begin patient dosing or not with the stem cell treatment for Aplastic Anemia. The FDA has to always make sure the dosing is safe and right to start testing in humans. Considering BMSN is using natural endothelial cells to naturally stimulate the bone marrow to produce blood< i don't see any problems.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.